Piper Sandler expressed continued confidence in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), maintaining an Overweight ...

Amgen (NASDAQ:AMGN – Get Free Report) had its target price increased by Piper Sandler from $310.00 to $329.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently ...

Piper Sandler adjusted its outlook on Health Catalyst Inc. (NASDAQ:HCAT) shares, reducing the price target to $8 from the previous $12, while maintaining an Overweight rating on the stock. Currently ...

Piper Sandler adjusted its stance on Q32 Bio Inc. (NASDAQ: QTTB), downgrading the biotech firm's stock rating from Overweight to Neutral and significantly reducing the price target to $4.00 from the ...

Piper Sandler Companies (PIPR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

Piper Sandler adjusted its outlook on Weatherford International plc (NASDAQ:WFRD), reducing the company’s price target to $82.00 from the previous $87.00 while maintaining a Neutral rating on the ...

Piper Sandler, a well-known investment firm, increased its price target on shares of Amgen (NASDAQ:AMGN) to $329.00, up from the previous target of $310.00. The firm has maintained its Overweight ...

Piper Sandler provided a preview for the Security & Infrastructure Software (ETR:SOWGn) sector's January quarter, expressing optimism about the upcoming earnings reports. The firm's analysis ...

Fintel reports that on January 31, 2025, Piper Sandler downgraded their outlook for Hershey (WBAG:HSY) from Neutral to Underweight. There are 2,171 funds or institutions reporting positions in ...

Fintel reports that on January 31, 2025, Piper Sandler downgraded their outlook for Mondelez International (SNSE:MDLZ) from Overweight to Neutral. There are 2,971 funds or institutions reporting ...

The U.S. Securities and Exchange Commission's (SEC) newly established Crypto Task Force is expected to provide much-needed regulatory clarity for institutional investors, according to a research note ...

Fintel reports that on January 31, 2025, Piper Sandler downgraded their outlook for Mondelez International (BRSE:MDLZ) from Overweight to Neutral. There are 2,973 funds or institutions reporting ...